SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer

www.nature.com

SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer

www.nature.com

paywallMB to

NatureEnglish · 9 days ago

Nature, Published online: 11 February 2026; doi:10.1038/s41586-026-10106-5

SLAMF6 functions exclusively as a T cell inhibitory receptor, which is triggered by cis homotypic interactions.

From Nature via this RSS feed

You must log in or # to comment.

Chat

Nature

nature

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !nature@ibbit.at

Community locked: only moderators can create posts. You can still comment on posts.

Nature is a weekly international journal publishing the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.

Don’t post archive.is links or full text of articles, you will receive a temp ban.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

6 users / day
15 users / week
30 users / month
64 users / 6 months
1 local subscriber
27 subscribers
2.56K Posts
17 Comments
Modlog